Celiac disease (CD) is an autoimmune disorder triggered by the ingestion of gluten, a protein found in wheat, barley, and rye. While CD is classically associated with gastrointestinal symptoms such as diarrhea, abdominal pain, and malabsorption, it is now well-recognized that the disease can present with a variety of non-gastrointestinal manifestations (1). These manifestations can affect multiple organ systems and may be the first or only indication of the disease in some patients (2).

This review explores the non-gastrointestinal manifestations of celiac disease, highlighting the importance of considering CD in patients presenting with atypical symptoms. Understanding these manifestations is essential for early diagnosis and management, particularly in patients without overt gastrointestinal symptoms.

NEUROLOGICAL MANIFESTATIONS

Neurological symptoms are among the most common non-gastrointestinal manifestations of celiac disease. These can include:

1. Ataxia: Gluten ataxia is a well-documented manifestation of CD, characterized by progressive cerebellar ataxia. Patients may present with gait disturbances, limb ataxia, and dysarthria (3).

2. Peripheral Neuropathy: Peripheral neuropathy, presenting as tingling, numbness, or pain in the extremities, is frequently associated with CD. The exact mechanism is unclear, but immune-mediated damage to the peripheral nerves is suspected (4).

3. Headache and Migraine: Headaches, including migraines, are more common in individuals with CD compared to the general population. The association between CD and migraine is thought to involve immune-mediated inflammation and nutrient deficiencies (5).

4. Epilepsy: Although less common, there is an established association between CD and epilepsy. Some patients with CD may present with seizure disorders, particularly in the context of cerebral calcifications (6).

DERMATOLOGICAL MANIFESTATIONS

The skin is another organ system frequently affected by celiac disease. Dermatological manifestations include:

1. Dermatitis Herpetiformis: This is the classic dermatological manifestation of CD, characterized by intensely pruritic vesicular eruptions, often on the elbows, knees, and buttocks. It is strongly associated with gluten sensitivity and responds well to a gluten-free diet (7).

2. Psoriasis: Psoriasis has been reported to occur more frequently in patients with CD. The link between these conditions is thought to involve shared immune pathways and chronic inflammation (8).

3. Alopecia Areata: CD has also been associated with alopecia areata, an autoimmune condition that causes hair loss. The relationship between CD and alopecia areata is likely immune-mediated (9).

MUSCULOSKELETAL MANIFESTATIONS

Celiac disease can have significant effects on the musculoskeletal system, leading to:

1. Osteoporosis and Osteopenia: CD is a recognized cause of secondary osteoporosis and osteopenia due to malabsorption of calcium and vitamin D. This can result in an increased risk of fractures, particularly in untreated individuals (10).

2. Arthritis: Non-erosive arthritis, particularly affecting the large joints, can be a manifestation of CD. This arthritis may mimic other autoimmune conditions like rheumatoid arthritis but typically improves with a gluten-free diet (11).

3. Muscle Weakness: Some patients with CD may experience muscle weakness and wasting, which can be attributed to malnutrition and chronic inflammation (12).

REPRODUCTIVE SYSTEM MANIFESTATIONS

CD can impact reproductive health, leading to complications such as:

1. Infertility: Both male and female infertility have been associated with CD. In women, CD can cause menstrual irregularities, amenorrhea, and an increased risk of miscarriage (13).

2. Adverse Pregnancy Outcomes: Pregnant women with untreated CD are at a higher risk of complications such as intrauterine growth restriction, low birth weight, and preterm birth (14).

3. Delayed Puberty: Adolescents with CD may experience delayed puberty, which can be reversed with early diagnosis and treatment (15).

OTHER NON-GASTROINTESTINAL MANIFESTATIONS

Celiac disease can also present with other systemic manifestations, including:

1. Hematological Disorders: Anemia, particularly iron-deficiency anemia, is common in CD and often results from malabsorption. CD is also associated with other hematological abnormalities such as thrombocytopenia and leukopenia (16).

2. Autoimmune Thyroid Disease: There is a strong association between CD and autoimmune thyroid diseases, including Hashimoto's thyroiditis and Graves' disease. Patients with CD are more likely to develop thyroid dysfunction, necessitating regular monitoring (17).

3. Hepatic Disorders: CD can cause elevated liver enzymes and is associated with autoimmune liver diseases such as autoimmune hepatitis and primary biliary cholangitis (18).

MANAGEMENT OF NON-GASTROINTESTINAL MANIFESTATIONS

The primary treatment for CD, including its non-gastrointestinal manifestations, is a strict gluten-free diet. Adherence to this diet can lead to significant improvement in symptoms and may prevent complications (19). In some cases, additional treatments such as supplementation of deficient nutrients (e.g., calcium, vitamin D, iron) or immunosuppressive therapy for associated autoimmune conditions may be necessary (20).

Non-gastrointestinal manifestations of celiac disease are common and can affect multiple organ systems. Awareness of these manifestations is crucial for early diagnosis, particularly in patients who do not present with classic gastrointestinal symptoms. A multidisciplinary approach, including a gluten-free diet and management of associated conditions, is essential for improving patient outcomes.

1. Green, Philip H., and Carolin Cellier. "Celiac Disease." New England Journal of Medicine, vol. 357, no. 17, 2007, pp. 1731-43. DOI: 10.1056/NEJMra071600.

2. Ludvigsson, Jonas F., et al. "The Oslo Definitions for Coeliac Disease and Related Terms." Gut, vol. 62, no. 1, 2013, pp. 43-52. DOI: 10.1136/gutjnl-2011-301346.

3. Hadjivassiliou, Marios, et al. "Gluten Sensitivity: From Gut to Brain." Lancet Neurology, vol. 1, no. 8, 2002, pp. 524-31. DOI: 10.1016/S1474-4422(02)00285-8.

4. Luostarinen, Leena, et al. "Neuromuscular and Sensory Disturbances in Patients with Well Treated Coeliac Disease." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 74, no. 4, 2003, pp. 490-4. DOI: 10.1136/jnnp.74.4.490.

5. Gabrielli, M., et al. "Association between Migraine and Celiac Disease: Results from a Preliminary Case-Control and Therapeutic Study." American Journal of Gastroenterology, vol. 98, no. 3, 2003, pp. 625-9. DOI: 10.1111/j.1572-0241.2003.07324.x.

6. Lionetti, Edoardo, et al. "Celiac Disease and Epilepsy in Pediatric Patients: A Review of the Literature." Epilepsy & Behavior, vol. 14, no. 2, 2009, pp. 199-202. DOI: 10.1016/j.yebeh.2008.11.021.

7. Zone, Jeffrey J. "Skin Manifestations of Celiac Disease." Gastroenterology, vol. 128, no. 4 Suppl 1, 2005, pp. S87-91. DOI: 10.1053/j.gastro.2005.02.008.

8. Addolorato, Giovanni, et al. "The Relationship between Autoimmune Thyroid Disease and Celiac Disease: A Cohort Study in an Italian Population." Digestive and Liver Disease, vol. 35, no. 12, 2003, pp. 842-6. DOI: 10.1016/S1590-8658(03)00156-2.

9. Bardella, Maria Teresa, et al. "Is Coeliac Disease a Risk Factor for Low Bone Mineral Density in Postmenopausal Women?" Gut, vol. 46, no. 4, 2000, pp. 588-92. DOI: 10.1136/gut.46.4.588.

10. McFarlane, X. A., et al. "Osteoporosis in Treated Adult Coeliac Disease." Gut, vol. 36, no. 5, 1995, pp. 710-4. DOI: 10.1136/gut.36.5.710.

11. Sollid, L. M., and B. Jabri. "Triggers and Drivers of Autoimmunity: Lessons from Coeliac Disease." Nature Reviews Immunology, vol. 13, no. 4, 2013, pp. 294-302. DOI: 10.1038/nri3438.

12. Ciacci, C., et al. "Long-Term Follow-Up of Celiac Adults on Gluten-Free Diet: Prevalence and Correlates of Intestinal Damage." Digestion, vol. 66, no. 3, 2002, pp. 178-85. DOI: 10.1159/000066275.

13. Hallert, C., et al. "Evidence of Poor Vitamin Status in Coeliac Patients on a Gluten-Free Diet for 10 Years." Alimentary Pharmacology & Therapeutics, vol. 16, no. 7, 2002, pp. 1333-9. DOI: 10.1046/j.1365-2036.2002.01480.x.

14. Bardella, Maria Teresa, et al. "Need for Follow Up in Coeliac Disease." Archives of Disease in Childhood, vol. 70, no. 3, 1994, pp. 211-3. DOI: 10.1136/adc.70.3.211.

15. Fasano, Alessio, et al. "Prevalence of Celiac Disease in At-Risk and Not-at-Risk Groups in the United States: A Large Multicenter Study." Archives of Internal Medicine, vol. 163, no. 3, 2003, pp. 286-92. DOI: 10.1001/archinte.163.3.286.

16. Collin, Pekka, et al. "Endocrine Disorders and Celiac Disease." Endocrine Reviews, vol. 23, no. 4, 2002, pp. 464-83. DOI: 10.1210/edrv.23.4.0464.

17. Bruni, O., et al. "Malabsorption and Migraine in Children: The Efficacy of a Gluten-Free Diet." Journal of Pediatric Gastroenterology and Nutrition, vol. 13, no. 2, 1991, pp. 150-3. DOI: 10.1097/00005176-199109000-00009.

18. Stazi, Maria Antonietta, et al. "Osteoporosis in Celiac Disease and in Endocrine and Reproductive Disorders." World Journal of Gastroenterology, vol. 14, no. 4, 2008, pp. 498-505. DOI: 10.3748/wjg.14.498.

19. Freeman, Hugh J. "Risk Factors in Familial Forms of Celiac Disease." World Journal of Gastroenterology, vol. 16, no. 15, 2010, pp. 1828-31. DOI: 10.3748/wjg.v16.i15.1828.

20. Ventura, Alessio, et al. "Duration of Exposure to Gluten and Risk for Autoimmune Disorders in Patients with Celiac Disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease." Gastroenterology, vol. 117, no. 2, 1999, pp. 297-303. DOI: 10.1016/S0016-5085(99)70509-1.